Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Optimising human factors within regulatory processes to accelerate safe biopharmaceutical innovation
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: PARSONS, Andrew (Reciprocal Minds Limited)
- Co-author(s): Andrew Parsons: Reciprocal Minds Limited, Welwyn Garden City, United Kingdom
Allison Morgan: Metis Clinical, Ascot, United Kingdom
Simon Whiteley: Whiteley Aerospace Safety Engineering & Management Limited, Swindon, United Kingdom
Crystal Ruff: Illumina, Cambridge, United Kingdom
Fiona Day: Beaconbrands , London, United Kingdom
Julia Mironova: Beaconbrands, London, United Kingdom
Brian Edwards: NDA Regulatory Science Ltd, Leatherhead, United Kingdom
BackgroundHuman factors (HF) allow optimisation of the interface between people and all aspects of a system. Despite recent technological advances, the basic principles of medicines development have not changed since the ’80 and have been stated to be “broken” .
MethodsUsing a system engineering model (STAMP)  the BP development process was.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019